(and dosage form):
Each tablet contains 25 mg of dipyridamole.
This product contains Tartrazine.
A.8 Medicines acting on blood and haemopoietic systems.
Dipyridamole is readily absorbed from the gastro-intestinal tract. It reduces platelet adhesiveness and aggregation. It reduces permeability of the red cell membrane to adenosine. Intracellular interaction between adenosine and ATP is inhibited, thus less ADP is formed. As a result of this mechanism the ADP induced aggregation and adhesiveness is reduced.
Conditions where reduction in platelet aggregation and/or adhesiveness is considered to be of therapeutic benefit.
Hypersensitivity. Patients with hypotension following myocardial infarction.
This product contains FD and C Yellow No. 5 (Tartazine) which may cause allergic type reactions (including Bronchial Asthma) in certain susceptible individuals. Although the overall incidence of Tartrazine sensitivity in the general population is currently thought to be low, it is frequently seen in patients who also have aspirin sensitivity.
DOSAGE AND DIRECTIONS FOR USE:
Four tablets four times a day (usually four tablets three times a day and four at bedtime). Where possible, dosage should commence with four tablets in the morning and evening for 5 days, four three times a day for 5 days and then four times a day. Aspirin potentiates the effect of dipyridamole and a reduction in dosage may be necessary.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Headache, vertigo, nausea, vomiting, skin rash, diarrhoea, flushing and a bitter taste, have been reported.
Dipyridamole can induce angina in patients.
Dipyridamole should be given with care to patients with hypotension.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
As under "Side-effects". Treatment is symptomatic and-supportive.
Orange coated tablets.
Securitainers of 100 tablets.
Protect from moisture, store below 25°C.
KEEP OUT OF REACH OF CHILDREN.
NAME AND BUSINESS ADDRESS OF APPLICANT:
7 Fairclough Road
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998